(Q43172342)

15 November 2017

Attenuation of precipitated morphine withdrawal symptoms by acute i.c.v. administration of a group II mGluR agonist (English)

1 reference

15 November 2017

1 reference

Fundytus ME

1

1 reference

15 November 2017

Coderre TJ

series ordinal

2

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

British Journal of Pharmacology

15 November 2017

1 reference

15 November 2017

121

1 reference

15 November 2017

3

1 reference

15 November 2017

511-514

1 reference

Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence

15 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

Evidence for the implication of phosphoinositol signal transduction in mu-opioid inhibition of DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Modulation of thymidine incorporation by kappa-opioid ligands in rat spinal cord-dorsal root ganglion co-cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Loss of protein kinase C-alpha beta in brain of heroin addicts and morphine-dependent rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Opioid receptor-coupled second messenger systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Chronic inhibition of intracellular Ca2+ release or protein kinase C activation significantly reduces the development of morphine dependence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Molecular characterization of NMDA and metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Molecular diversity of glutamate receptors and implications for brain function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Trans-ACPD, a selective agonist of the phosphoinositide-coupled excitatory amino acid receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Morphine withdrawal in vitro: potentiation of agonist-dependent polyphosphoinositide breakdown

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

The metabotropic glutamate receptors: structure and functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Metabotropic glutamate receptors in brain function and pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

3,5-dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Inhibition of Cyclic AMP Formation by a Selective Metabotropic Glutamate Receptor Agonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

In Vitro and In Vivo Pharmacology oftrans-andcis-(±)-1-Amino-1,3-Cyclopentanedicarboxylic Acid: Dissociation of Metabotropic and Ionotropic Excitatory Amino Acid Receptor Effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Comparison of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD)- and 1R,3S-ACPD-stimulated brain phosphoinositide hydrolysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Phenylglycine derivatives as antagonists of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701174

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701174

1 reference

15 November 2017

1 reference

15 November 2017

PubMed publication ID

9179394

1 reference